The customer contacted siemens customer care center (ccc) and reported that they obtained different activated partial thromboplastin time (aptt) results for a patient on the bcs xp system.Upon obtaining different results on the patient samples, the customer ran quality controls (qcs), resulting within expected ranges.As per the siemens technical solutions center (tsc) specialist's instructions, the customer ran a validation test, which recovered as expected.Since qc recovery and the validation test recovered within specification, the tsc specialist determined that there was no indication of a system or reagent malfunction.The customer declined further investigation and indicated that the sample draws were potentially mixed; this sample handling use error potentially contributed to the different results obtained on samples from the affected patient.The system and reagent are performing according to specifications.No further evaluation of these devices is required.
|